Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

DHFRL1 Antibody (OTI1E2), PE, Novus Biologicals™
SDP

Catalog No. NB288138 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB288138 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB288138 Supplier Novus Biologicals Supplier No. NBP272459PE
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

DHFRL1 Monoclonal antibody specifically detects DHFRL1 in Human, Mouse, Canine, Monkey samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence

Specifications

Antigen DHFRL1
Applications Western Blot, Flow Cytometry, Immunocytochemistry
Classification Monoclonal
Clone OTI1E2
Conjugate PE
Dilution Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Formulation PBS
Gene Alias DHFRP4, dihydrofolate reductase pseudogene 4, dihydrofolate reductase-like 1, dihydrofolate reductase-like protein 1, EC 1.5.1.-, EC 1.5.1.3, FLJ16119
Host Species Mouse
Immunogen Human recombinant protein fragment corresponding to amino acids 4-185 of human DHFRL1(NP_789785) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 200895
Target Species Human, Mouse, Canine, Monkey
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.